| 000 | 01172 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250518021152.0 | ||
| 264 | 0 | _c20190130 | |
| 008 | 201901s 0 0 fre d | ||
| 022 | _a1769-6917 | ||
| 024 | 7 |
_a10.1016/S0007-4551(19)30051-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPinturaud, Marine | |
| 245 | 0 | 0 |
_aNone _h[electronic resource] |
| 260 |
_bBulletin du cancer _cDec 2018 |
||
| 300 |
_aS205-S213 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aContinuity of Patient Care |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy, Adoptive _xadverse effects |
| 650 | 0 | 4 |
_aPharmacies _xorganization & administration |
| 650 | 0 | 4 | _aPharmacists |
| 650 | 0 | 4 |
_aPharmacy Service, Hospital _xorganization & administration |
| 650 | 0 | 4 | _aProfessional Role |
| 650 | 0 | 4 | _aReceptors, Chimeric Antigen |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aVasseur, Michèle | |
| 700 | 1 | _aOdou, Pascal | |
| 773 | 0 |
_tBulletin du cancer _gvol. 105 Suppl 2 _gp. S205-S213 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0007-4551(19)30051-7 _zAvailable from publisher's website |
| 999 |
_c29296648 _d29296648 |
||